799 related articles for article (PubMed ID: 23182534)
21. Urine albumin and serum uric acid are important determinants of serum 25 hydroxyvitamin D level in pre-dialysis chronic kidney disease patients.
Fayed A; El Nokeety MM; Heikal AA; Sadek KM; Hammad H; Abdulazim DO; Salem MM; Sharaf El Din UA;
Ren Fail; 2019 Nov; 41(1):540-546. PubMed ID: 31234687
[TBL] [Abstract][Full Text] [Related]
22. The specific relationship between vitamin D deficiency and diabetic nephropathy among patients with advanced chronic kidney disease: a cross-sectional study in Gran Canaria, Spain.
Sánchez-Hernández RM; García-Cantón C; Lorenzo DL; Quevedo V; Bosch E; López-Ríos L; Riaño M; Boronat M
Clin Nephrol; 2015 Apr; 83(4):218-24. PubMed ID: 25828886
[TBL] [Abstract][Full Text] [Related]
23. The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008-2011.
Lee YH; Kim JE; Roh YH; Choi HR; Rhee Y; Kang DR; Lim SK
J Clin Endocrinol Metab; 2014 Oct; 99(10):3879-88. PubMed ID: 24878040
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D deficiency and insufficiency in patients with chronic kidney disease.
Diniz HF; Romão MF; Elias RM; Romão Júnior JE
J Bras Nefrol; 2012 Mar; 34(1):58-63. PubMed ID: 22441183
[TBL] [Abstract][Full Text] [Related]
25. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
27. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D status of chronic kidney disease patients living in a sunny country.
Cuppari L; Carvalho AB; Draibe SA
J Ren Nutr; 2008 Sep; 18(5):408-14. PubMed ID: 18721735
[TBL] [Abstract][Full Text] [Related]
29. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
Olmos JM; Hernández JL; García-Velasco P; Martínez J; Llorca J; González-Macías J
Osteoporos Int; 2016 Jan; 27(1):105-13. PubMed ID: 26134682
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease.
Rucker D; Tonelli M; Coles MG; Yoo S; Young K; McMahon AW
J Nephrol; 2009; 22(1):75-82. PubMed ID: 19229821
[TBL] [Abstract][Full Text] [Related]
31. An epidemiology survey of vitamin D deficiency and its influencing factors.
Jiang W; Wu DB; Xiao GB; Ding B; Chen EQ
Med Clin (Barc); 2020 Jan; 154(1):7-12. PubMed ID: 31133232
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and biochemical characteristics of predialysis patients in terms of 25 hydroxy vitamin D levels].
Rodríguez Villarreal I; Ortega O; Gallar P; Sánchez M; Callejas R; Gracia C; García la Calle C; Ortiz M; Herrero JC; Mon C; Oliet A; Vigil A
Nefrologia; 2011; 31(2):185-91. PubMed ID: 21461012
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study.
González EA; Sachdeva A; Oliver DA; Martin KJ
Am J Nephrol; 2004; 24(5):503-10. PubMed ID: 15452403
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D levels, vitamin D supplementation, and prognosis in patients with chronic kidney disease
.
Namir Y; Cohen MJ; Haviv YS; Slotki I; Shavit L
Clin Nephrol; 2016 Oct; 86(10):165-74. PubMed ID: 27616756
[TBL] [Abstract][Full Text] [Related]
35. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis.
Cho HY; Hyun HS; Kang HG; Ha IS; Cheong HI
Perit Dial Int; 2013; 33(4):398-404. PubMed ID: 23209039
[TBL] [Abstract][Full Text] [Related]
37. Posterior urethral valves: Metabolic consequences in a cohort of patients.
Sarhan O; Nakshabandi Z; Alghanbar M; Alotay A; Sherif I; Whitehead C; El-Husseini A
J Pediatr Urol; 2015 Aug; 11(4):216.e1-6. PubMed ID: 26096436
[TBL] [Abstract][Full Text] [Related]
38. 25-hydroxyvitamin D deficiency in renal transplant recipients.
Querings K; Girndt M; Geisel J; Georg T; Tilgen W; Reichrath J
J Clin Endocrinol Metab; 2006 Feb; 91(2):526-9. PubMed ID: 16303843
[TBL] [Abstract][Full Text] [Related]
39. [25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with advanced chronic kidney disease].
García-Cantón C; Bosch E; Auyanet I; Ramírez A; Rossique P; Culebras C; Sánchez A; Toledo A; Lago M; Esparza N; Checa MD
Nefrologia; 2010; 30(4):435-42. PubMed ID: 20651885
[TBL] [Abstract][Full Text] [Related]
40. Body adiposity predictors of vitamin D status in nondialyzed patients with chronic kidney disease: A cross-sectional analysis in a tropical climate city.
Barreto Silva MI; Cavalieri VV; Lemos CC; Klein MR; Bregman R
Nutrition; 2017 Jan; 33():240-247. PubMed ID: 27692990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
